Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione.
D000735:Androstenedione / Q000378:metabolism* / Q000494:pharmacology; D000737:Androstenols / Q000378:metabolism; D002845:Chromatography; D002855:Chromatography, Thin Layer; D003486:Cyanides / Q000494:pharmacology; D004958:Estradiol / Q000096:biosynthesis; D004970:Estrone / Q000096:biosynthesis; D005260:Female; D006801:Humans; D006900:Hydroxylation; D007700:Kinetics; D008861:Microsomes / Q000187:drug effects / Q000378:metabolism*; D009249:NADP / Q000378:metabolism*; D010084:Oxidation-Reduction; D010101:Oxygen Consumption; D010920:Placenta / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D011247:Pregnancy; D012822:Silicon Dioxide; D013256:Steroids / Q000494:pharmacology; D013997:Time Factors; D014316:Tritium
D000737:Androstenols; D003486:Cyanides; D013256:Steroids; D014316:Tritium; D004970:Estrone; D000735:Androstenedione; D004958:Estradiol; D009249:NADP; D012822:Silicon Dioxide